title: Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets.
authors.forename: Henrik
authors.initials: H
authors.lastname: Watz
authors.forename: Knut
authors.initials: K
authors.lastname: Engels
authors.forename: Siegfried
authors.initials: S
authors.lastname: Loeschke
authors.forename: Michael
authors.initials: M
authors.lastname: Amthor
authors.forename: Detlef
authors.initials: D
authors.lastname: Kirsten
authors.forename: Helgo
authors.initials: H
authors.lastname: Magnussen
mesh_terms: D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D018192:Lymphangioleiomyomatosis / Q000378:metabolism*; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D020794:Receptor Protein-Tyrosine Kinases